Open AccessAbstract 5213: HRH1 inhibition enhances antitumor therapeutic responses through ERK activation in breast cancer
Author(s) -
Patricia FernándezNogueira,
Aleix Noguera Castells,
Gabriela Orellana,
Leire Recalde Percaz,
Nuria Moragas Garcia,
Anna Lopez Plana,
Patricia Jauregui Jimenez,
Maria Neus Carbó Carbó,
Pedro Gascon Villaplana,
Paloma Bragado Domingo,
Mario Mancino
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-5213
Subject(s) - cancer research , mapk/erk pathway , cell growth , biology , apoptosis , breast cancer , downregulation and upregulation , cancer , signal transduction , medicine , microbiology and biotechnology , biochemistry , gene